Results 231 to 240 of about 379,930 (351)

Breast microcalcifications as indicators of bone metastasis risk in early-stage breast cancer. [PDF]

Sci Rep
Giorello MB, Borzone FR, Padin MDR, Mora MF, Wernicke A, Labovsky V, Chasseing NA.   +6 more
europepmc   +1 more source

Mucosal‐Associated Invariant T Cells in Rheumatic Diseases

Arthritis &Rheumatology, EarlyView.
Mucosal‐associated invariant T (MAIT) cells are innate‐like T cells defined by their semi‐invariant T cell receptor and restriction by the major histocompatibility complex class I–related molecule (MR1). These cells are primarily activated by microbial‐derived metabolites presented by MR1 or by cytokines.
Manon Lesturgie‐Talarek, Virginie Gonzalez, Lucie Beaudoin, Noémie Sénot, Corinne Miceli‐Richard, Yannick Allanore, Agnès Lehuen, Jerôme Avouac   +7 more
wiley   +1 more source

Ensemble machine learning models for predicting bone metastasis in bladder cancer. [PDF]

Front Oncol
Yu ZJ, Xu XD, Zou XC, Su P, Chao HC, Zeng T.   +5 more
europepmc   +1 more source

Supplementary Figure 1 from Targeting c-Jun is a potential therapy for luminal breast cancer bone metastasis

Yuxuan Han, Shota Katayama, Mitsuru Futakuchi, Kazuya Nakamichi, Yutaro Wakabayashi, Mai Sakamoto, Jun Nakayama, Kentaro Semba   +7 more
openalex   +1 more source

A Case of Canine Hepatocellular Carcinoma with Bone Metastasis

, 2008
Takanori Sasaki, Kenji Tani, Masanobu GORYO, Reeko Sato, Masaaki Katayama, Shinobu AOKI   +5 more
openalex   +2 more sources

Identification of histone deacetylase inhibitor targeting type I interferon and B‐cell abnormalities in systemic lupus erythematosus

Arthritis &Rheumatology, Accepted Article.
Objective Systemic lupus erythematosus (SLE) is characterized by increased type I interferon (IFN‐I) and autoantibody production. This study aimed to identify drugs that can inhibit both IFN‐I and autoantibody production. Methods We identified an inhibitor of IFN‐I production from a chemical library.
Takehiro Hirayama, Hachiro Konaka, Yasuhiro Kato, Takayuki Shibahara, Chisato Nishizawa, Kohei Tsujimoto, JeongHoon Park, Eri Itotagawa, Tatsunori Jo, Masayuki Nishide, Sumiyuki Nishida, Yoshihito Shima, Masashi Narazaki, Wataru Aoki, Ken J Ishii, Hyota Takamatsu, Atsushi Kumanogoh   +16 more
wiley   +1 more source

HMGB1 orchestrates tumor-osteoclast crosstalk to drive bone metastasis in hepatocellular carcinoma. [PDF]

Cell Death Dis
Chen YZ, Xu D, Jia YX, Ma J, Xiang ZL.
europepmc   +1 more source

Pulmonary carcinoid tumor presenting with widespread bone metastasis

, 2012
Oğuzhan Okutan, Ömer Ayten, Ersin Demirer, Necla Ugan, Zafer Kartaloğlu   +4 more
openalex   +1 more source

Plasma Proteomics Identifies TAOK3 as a Potential Biomarker of Rheumatoid Arthritis Activity and a Novel Therapeutic Target

Arthritis &Rheumatology, Accepted Article.
Objective Bone destruction associated with active rheumatoid arthritis (RA) remains a major therapeutic challenge, with a lack of reliable molecular markers reflecting bone injury. This study aims to identify novel biomarkers linked to bone destruction in active RA through proteomic analysis, providing new strategies for precise monitoring and targeted
Pengfei Xin, Wenzhen Li, Xinyu A, Jun Shen, Xiaohui Meng, Yanqin Bian, Haihui Han, Zheng Xiang, Lei Ran, Songtao Sun, Jun Xie, Tao Yue, Qi Zhu, Xiaoming Zhang, Lu Xie, Lianbo Xiao   +15 more
wiley   +1 more source

Exosome-transmitted long noncoding RNA SNHG1 promotes prostate cancer bone metastasis via YBX1/MMP16 axis. [PDF]

Cell Death Discov
Yang T, Luo J, Long Z, Wu J, Chen W, Zhou X, Zou L, Cen S, Zhong C, Lu J, Zheng P, Wei A, Lv D, Mao X.   +13 more
europepmc   +1 more source